Observing predictors of pituitary tumor recurrence
Pituitary Tumor Surveillance: Pathogenetic Correlation
This study looks at what factors might cause pituitary tumors to come back or stay active in patients who have had these tumors.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1250 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Cedars-Sinai Medical Center Academic / other |
| Locations | 1 site (Los Angeles, California) |
| Trial ID | NCT00599092 on ClinicalTrials.gov |
What this trial studies
This study aims to observe the predictors of recurrence and markers of persistent disease activity in patients with pituitary mass lesions. It involves the computerized collection of comprehensive demographic, therapeutic, pathologic, and outcome information from these patients. By analyzing this data, researchers hope to identify factors that contribute to tumor recurrence and ongoing disease activity.
Who should consider this trial
Good fit: Ideal candidates for this study are patients with confirmed pituitary disease.
Not a fit: Patients without confirmed pituitary disease will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved monitoring and management strategies for patients with pituitary tumors.
How similar studies have performed: While this approach is observational, similar studies have shown success in identifying predictors of tumor recurrence in other types of cancers.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients with confirmed pituitary disease Exclusion Criteria: * patients who do not have confirmed pituitary disease
Where this trial is running
Los Angeles, California
- Cedars-Sinai Medical Center, Pituitary Center — Los Angeles, California, United States (Recruiting)
Study contacts
- Principal investigator: Shlomo Melmed, MD — Cedars-Sinai Medical Center, Pituitary Center
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.